Substance
ETONOGESTREL
Global reference: every product and company linked to this substance.
- cas: 54048-10-1
- ncit: C47528
- pubchem_cid: 6917715
- rxnorm: 14584
- unii: 304GTH6RNH
etonogestrel [INN] · ETONOGESTREL [USAN] · Etonogestrel [WHO-DD] · IMPLANON · ORG 3236 · ORG-3236
Revenue by product (3)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| ORGANON & CO. COMMON STOCK | IMPLANON | Q2 2026 | $230.0M |
| ORGANON & CO. COMMON STOCK | NEXPLANON | Q2 2026 | $230.0M |
| ORGANON & CO. COMMON STOCK | NUVARING | Q2 2026 | $27.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (7)
- ELURYNG · AMNEAL PHARMACEUTICALS INC. CLASS A COMMON STOCK
- ETHINYL ESTRADIOL; ETONOGESTREL · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- HALOETTE · DR. REDDY'S LABORATORIES LTD COMMON STOCK
- IMPLANON · ORGANON & CO. COMMON STOCK
- NEXPLANON · ORGANON & CO. COMMON STOCK
- NUVARING · ORGANON & CO. COMMON STOCK
- VERARING · DR. REDDY'S LABORATORIES LTD COMMON STOCK